Search Results - "Schiellerup SP"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

    Authors: Gadgaard S van der Velden WJC Schiellerup SP et al.

    Source: British journal of pharmacology [Br J Pharmacol] 2022 May; Vol. 179 (9), pp. 1998-2015. Date of Electronic Publication: 2022 Jan 11.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system.

    Authors: Gadgaard S Windeløv JA Schiellerup SP et al.

    Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Apr; Vol. 160, pp. 114383. Date of Electronic Publication: 2023 Feb 11.

    Publication Type: Journal Article

    Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

    Save to List
  3. 3

    Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

    Authors: Schiellerup SP Skov-Jeppesen K Windeløv JA et al.

    Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Feb 26; Vol. 10, pp. 75. Date of Electronic Publication: 2019 Feb 26 (Print Publication: 2019).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.

    Authors: Gabe MBN Skov-Jeppesen K Gasbjerg LS et al.

    Source: Pharmacological research [Pharmacol Res] 2022 Feb; Vol. 176, pp. 106058. Date of Electronic Publication: 2022 Jan 04.

    Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

    Save to List
  5. 5

    GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats.

    Authors: van der Velden WJC Smit FX Christiansen CB et al.

    Source: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2021 Jan 19; Vol. 4 (1), pp. 296-313. Date of Electronic Publication: 2021 Jan 19 (Print Publication: 2021).

    Publication Type: Journal Article

    Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE

    Save to List

Search Tools: